Please login to the form below
New Accounts, October, 2009, Advertising
New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| AAH (UK) | N/A | Corporate | Euro RSCG Life |
| GSK UK | Eumovate and Eumocream | Dermatology | Euro RSCG Life |
| Johnson & Johnson EMA | Vision care | Ophthalmology | Euro RSCG Life |
| Lundbeck | Cipralex | Mental health | MSA Digital |
| Lundbeck | Ebixa | Central nervous system | MSA Digital |
| Merck-Serono Global | N/A | Fertility portfolio | Euro RSCG Life |
| Mundipharma International | New product | Respiratory | Health 4 Brands |
| Mundipharma International | New product | Pain | Health 4 Brands |
| Novo Nordisk | Levemir | Diabetes | Bedgebury Communications |
| Takeda | Amias | Cardiovascular | MSA Digital |
| Teva | Qvar | Respiratory | MSA Digital |
| Teva | Nasofan | Allergies | MSA Digital |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
